GPCPD1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	27 studies	32% ± 13%	Explore
endothelial cell	24 studies	35% ± 21%	Explore
classical monocyte	23 studies	35% ± 12%	Explore
monocyte	15 studies	43% ± 20%	Explore
non-classical monocyte	15 studies	29% ± 9%	Explore
B cell	14 studies	25% ± 7%	Explore
microglial cell	11 studies	40% ± 13%	Explore
myeloid cell	10 studies	37% ± 14%	Explore
fibroblast	10 studies	24% ± 12%	Explore
dendritic cell	9 studies	30% ± 10%	Explore
natural killer cell	9 studies	24% ± 5%	Explore
CD4-positive, alpha-beta T cell	9 studies	23% ± 7%	Explore
pericyte	9 studies	28% ± 14%	Explore
regulatory T cell	9 studies	20% ± 4%	Explore
alveolar macrophage	8 studies	58% ± 20%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	20% ± 3%	Explore
astrocyte	8 studies	28% ± 10%	Explore
oligodendrocyte precursor cell	8 studies	33% ± 13%	Explore
T cell	7 studies	25% ± 5%	Explore
neutrophil	7 studies	27% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	19% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	22% ± 4%	Explore
naive B cell	6 studies	18% ± 3%	Explore
adipocyte	6 studies	29% ± 7%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	21% ± 6%	Explore
glutamatergic neuron	5 studies	39% ± 14%	Explore
conventional dendritic cell	5 studies	28% ± 9%	Explore
interneuron	5 studies	36% ± 16%	Explore
epithelial cell	5 studies	41% ± 15%	Explore
CD8-positive, alpha-beta T cell	5 studies	21% ± 1%	Explore
type II pneumocyte	5 studies	24% ± 5%	Explore
GABAergic neuron	5 studies	32% ± 7%	Explore
smooth muscle cell	5 studies	24% ± 6%	Explore
CD8-positive, alpha-beta memory T cell	5 studies	19% ± 2%	Explore
squamous epithelial cell	4 studies	38% ± 23%	Explore
mononuclear phagocyte	4 studies	26% ± 5%	Explore
mucosal invariant T cell	4 studies	22% ± 5%	Explore
ciliated cell	4 studies	34% ± 10%	Explore
lymphocyte	4 studies	38% ± 15%	Explore
respiratory goblet cell	4 studies	40% ± 9%	Explore
leukocyte	4 studies	33% ± 13%	Explore
endothelial cell of lymphatic vessel	4 studies	25% ± 4%	Explore
erythrocyte	4 studies	47% ± 28%	Explore
basal cell	4 studies	45% ± 19%	Explore
goblet cell	4 studies	33% ± 24%	Explore
granule cell	3 studies	22% ± 7%	Explore
retinal ganglion cell	3 studies	41% ± 9%	Explore
plasma cell	3 studies	33% ± 2%	Explore
club cell	3 studies	21% ± 2%	Explore
serous secreting cell	3 studies	19% ± 0%	Explore
mesothelial cell	3 studies	22% ± 4%	Explore
tissue-resident macrophage	3 studies	31% ± 9%	Explore
intermediate monocyte	3 studies	44% ± 18%	Explore
gamma-delta T cell	3 studies	34% ± 13%	Explore
retinal pigment epithelial cell	3 studies	35% ± 17%	Explore
abnormal cell	3 studies	23% ± 6%	Explore
connective tissue cell	3 studies	24% ± 5%	Explore
mast cell	3 studies	32% ± 10%	Explore
vein endothelial cell	3 studies	38% ± 23%	Explore
neuron	3 studies	41% ± 10%	Explore
mural cell	3 studies	55% ± 9%	Explore
mature NK T cell	3 studies	21% ± 4%	Explore
mucus secreting cell	3 studies	36% ± 20%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	11 studies	29% ± 12%	Explore
brain	9 studies	29% ± 8%	Explore
peripheral blood	7 studies	25% ± 7%	Explore
adipose	4 studies	24% ± 5%	Explore
bone marrow	3 studies	22% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
thymus	100%	5561.18	653 / 653	100%	32.96	603 / 605
esophagus	100%	4379.54	1444 / 1445	99%	29.69	182 / 183
lung	100%	10144.39	578 / 578	99%	35.92	1146 / 1155
prostate	100%	4106.04	245 / 245	99%	15.49	496 / 502
breast	100%	4408.77	459 / 459	99%	21.62	1103 / 1118
uterus	100%	4201.66	170 / 170	98%	28.75	451 / 459
brain	98%	3900.46	2590 / 2642	100%	27.15	705 / 705
intestine	100%	4055.84	965 / 966	98%	30.59	517 / 527
adrenal gland	100%	4510.00	258 / 258	97%	15.56	222 / 230
stomach	97%	2797.28	350 / 359	99%	31.30	283 / 286
bladder	100%	3687.48	21 / 21	96%	21.93	483 / 504
ovary	100%	6794.19	180 / 180	93%	14.12	402 / 430
kidney	100%	2836.33	89 / 89	93%	16.34	834 / 901
pancreas	91%	1745.59	298 / 328	97%	19.79	173 / 178
skin	100%	3289.70	1806 / 1809	82%	12.05	388 / 472
liver	73%	1318.87	164 / 226	63%	5.95	256 / 406
adipose	100%	4862.35	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	25.29	29 / 29
spleen	100%	9577.51	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	23.57	45 / 45
peripheral blood	100%	10765.94	928 / 929	0%	0	0 / 0
blood vessel	100%	4337.19	1330 / 1335	0%	0	0 / 0
heart	93%	2634.46	801 / 861	0%	0	0 / 0
muscle	92%	2750.75	739 / 803	0%	0	0 / 0
eye	0%	0	0 / 0	64%	7.54	51 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0007519	Biological process	skeletal muscle tissue development
GO_0046475	Biological process	glycerophospholipid catabolic process
GO_0005829	Cellular component	cytosol
GO_2001070	Molecular function	starch binding
GO_0047389	Molecular function	glycerophosphocholine phosphodiesterase activity

IV. Literature review

[source]

Gene name	GPCPD1
Protein name	Glycerophosphocholine phosphodiesterase 1 Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5)
Synonyms	GDE5 KIAA1434
Description	FUNCTION: May be involved in the negative regulation of skeletal muscle differentiation, independently of its glycerophosphocholine phosphodiesterase activity. .
Accessions	ENST00000481690.2 A0A0J9YY12 Q9NPB8 H0Y565 ENST00000418646.5 ENST00000633552.1 ENST00000379019.7 A0A0J9YVP8

GPCPD1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review